Attila Nakeeb to Pancreatic Ducts
This is a "connection" page, showing publications Attila Nakeeb has written about Pancreatic Ducts.
Connection Strength
1.284
-
Maatman TK, Mahajan S, Roch AM, Ceppa EP, House MG, Nakeeb A, Schmidt CM, Zyromski NJ. Disconnected pancreatic duct syndrome predicts failure of percutaneous therapy in necrotizing pancreatitis. Pancreatology. 2020 Apr; 20(3):362-368.
Score: 0.165
-
Maatman TK, Roch AM, Lewellen KA, Heimberger MA, Ceppa EP, House MG, Nakeeb A, Schmidt CM, Zyromski NJ. Disconnected Pancreatic Duct Syndrome: Spectrum of Operative Management. J Surg Res. 2020 03; 247:297-303.
Score: 0.162
-
Roch AM, Schneider J, Carr RA, Lancaster WP, House MG, Zyromski NJ, Nakeeb A, Schmidt CM, Ceppa EP. Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma? J Surg Oncol. 2019 May; 119(6):777-783.
Score: 0.153
-
Simpson RE, Ceppa EP, Wu HH, Akisik F, House MG, Zyromski NJ, Nakeeb A, Al-Haddad MA, DeWitt JM, Sherman S, Schmidt CM. The Dilemma of the Dilated Main Pancreatic Duct in the Distal Pancreatic Remnant After Proximal Pancreatectomy for IPMN. J Gastrointest Surg. 2019 08; 23(8):1593-1603.
Score: 0.153
-
Cioffi JL, McDuffie LA, Roch AM, Zyromski NJ, Ceppa EP, Schmidt CM, Nakeeb A, House MG. Pancreaticojejunostomy Stricture After Pancreatoduodenectomy: Outcomes After Operative Revision. J Gastrointest Surg. 2016 Feb; 20(2):293-9.
Score: 0.123
-
Ceppa EP, Roch AM, Cioffi JL, Sharma N, Easler JJ, DeWitt JM, House MG, Zyromski NJ, Nakeeb A, Schmidt CM. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm. Surgery. 2015 Oct; 158(4):937-44; discussion 944-5.
Score: 0.120
-
Roch AM, Ceppa EP, Al-Haddad MA, DeWitt JM, House MG, Zyromski NJ, Nakeeb A, Schmidt CM. The natural history of main duct-involved, mixed-type intraductal papillary mucinous neoplasm: parameters predictive of progression. Ann Surg. 2014 Oct; 260(4):680-8; discussion 688-90.
Score: 0.114
-
Roch AM, DeWitt JM, Al-Haddad MA, Schmidt CM, Ceppa EP, House MG, Zyromski NJ, Nakeeb A, Schmidt CM. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients. J Am Coll Surg. 2014 Jul; 219(1):122-9.
Score: 0.110
-
Barron MR, Roch AM, Waters JA, Parikh JA, DeWitt JM, Al-Haddad MA, Ceppa EP, House MG, Zyromski NJ, Nakeeb A, Pitt HA, Schmidt CM. Does preoperative cross-sectional imaging accurately predict main duct involvement in intraductal papillary mucinous neoplasm? J Gastrointest Surg. 2014 Mar; 18(3):447-55; discussion 5455-6.
Score: 0.108
-
Simpson RE, Cockerill NJ, Yip-Schneider MT, Ceppa EP, House MG, Zyromski NJ, Nakeeb A, Al-Haddad MA, Schmidt CM. Clinical criteria for integrated molecular pathology in intraductal papillary mucinous neoplasm: less is more. HPB (Oxford). 2019 05; 21(5):574-581.
Score: 0.038
-
Simpson RE, Cockerill NJ, Yip-Schneider MT, Ceppa EP, House MG, Zyromski NJ, Nakeeb A, Al-Haddad MA, Schmidt CM. DNA profile components predict malignant outcomes in select cases of intraductal papillary mucinous neoplasm with negative cytology. Surgery. 2018 10; 164(4):712-718.
Score: 0.037